Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Effect of obesity on prognosis after early-stage breast cancerMarianne Ewertz, Maj-Britt Jensen, Katrín Á Gunnarsdóttir, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 30, 2018
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancerKaren-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, et al.
International Journal of Cancer|January 22, 2019
First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignanciesSandra M M Irenaeus, Dorte Nielsen, Peter Ellmark, et al.
The Oncologist|May 8, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patientsMorten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2018
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancerTroels Dreier Christensen, Jesper Andreas Palshof, Finn Ole Larsen, et al.
American Heart Journal|July 15, 2023
Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide studyAnn Banke, Charlotte Andersson, Maria D'Souza, et al.
Cancer Medicine|October 17, 2022
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancerSidsel C Lindgaard, Zsófia Sztupinszki, Emil Maag, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2017
Risk factors for brain metastases in patients with metastatic colorectal cancerTroels Dreier Christensen, Jesper Andreas Palshof, Finn Ole Larsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 3, 2011
Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancerFinn Ole Larsen, Per Pfeiffer, Dorte Nielsen, et al.
Pageof 9